Base pair | Jotup

Scale Biosciences Unveils Platform for Dramatic Scaling of Single-Cell Experiments and Announces Partnerships to Drive Ease of Use and Enable New Biological Insights

Retrieved on:

Montag, Februar 5, 2024

This technology will form the basis for future ScaleBio innovation and product development.

Key Points:

This technology will form the basis for future ScaleBio innovation and product development.
“As we look to the future, we are focused on enabling dramatic scaling of single cell-based experiments with higher throughputs across a wider range of parameters and applications,” said Giovanna Prout, CEO of ScaleBio.
At AGBT, the companies will share combined datasets of high-resolution data from mouse brain tissue sections generated using their respective technologies.
ScaleBio also has a partnership with Basepair to offer the ScaleBio Seq Suite on the Basepair platform.

Complete Genomics opens $3.2 million manufacturing facility at its San Jose headquarters

Retrieved on:

Donnerstag, November 16, 2023

Foot, International Organization (journal), WGS, Research, SAN, Engineering, Entrepreneurship, Integrated DNA Technologies, Completeness, Base pair, ISO, Complete Genomics, Genomics, Integration, Biotechnology

SAN JOSE, Calif., Nov. 16, 2023 /PRNewswire/ -- Complete Genomics, a pioneering genomic sequencing company, today announced plans for the opening of a $3.2 million manufacturing facility within its headquarters in San Jose, California.

Key Points:

SAN JOSE, Calif., Nov. 16, 2023 /PRNewswire/ -- Complete Genomics, a pioneering genomic sequencing company, today announced plans for the opening of a $3.2 million manufacturing facility within its headquarters in San Jose, California.
The facility, scheduled to open in March 2024, will give Complete Genomics customers access to a U.S.-based supply chain translating into faster delivery times for its next generation sequencing products.
The new facility will house Complete Genomics' research and development, engineering and ISO (International Organization for Standardization) manufacturing operations.
In May 2017, Complete Genomics moved to its current 78,979 square foot location in San Jose, which also includes a warehousing facility.

Complete Genomics and Basepair™ Announce Technology Integration Partnership

Retrieved on:

Donnerstag, November 2, 2023

Complete Genomics, Knowledge, Genomics, Amazon Web Services, NGS, Partnership, Workflow, AWS, Marketing, SAN, Completeness, Cryptocurrency, Antibiotics, Base pair

SAN JOSE, Calif. and NEW YORK, Nov. 2, 2023 /PRNewswire/ -- Complete Genomics and Basepair, Inc today announced a technology integration partnership to accelerate the analysis and interpretation of genomic data generated by Complete Genomics' DNBSEQTM sequencing platforms*.

Key Points:

SAN JOSE, Calif. and NEW YORK, Nov. 2, 2023 /PRNewswire/ -- Complete Genomics and Basepair, Inc today announced a technology integration partnership to accelerate the analysis and interpretation of genomic data generated by Complete Genomics' DNBSEQTM sequencing platforms*.
The partnership gives Complete Genomics' customers the ability for seamless access to Basepair's bioinformatics platform deployed on Amazon Web Services (AWS) and use its easy-to-use point & click user interface to launch and orchestrate NGS workflows in the cloud, either by provisioning in their own accounts or via Basepair's hosted service.
"Our partnership with Basepair is another way for Complete Genomics to make our customer experience more seamless at all stages of the NGS workflow," Tarbox said.
"It's long been the holy grail of genomics to deliver a seamless sample to answer experience for scientists and clinicians," Basepair's CEO & Founder, Amit Sinha, said.

Scale Biosciences and Basepair to Democratize Single Cell Sequencing Data Analysis

Retrieved on:

Montag, August 21, 2023

Software, Research, Pharmaceutical, Oncology, Data Management, Technology, Genetics, Health Technology, Science, Biotechnology, Other Science, Health, Organization, GUI, BCL, Library, Doctor of Philosophy, Base pair

Scale Biosciences, a pioneer in single-cell sequencing technology, today announced a new collaboration with Basepair to provide point and click bioinformatic analysis of single-cell data produced with its patented and disruptive combinatorial indexing technology.

Key Points:

Scale Biosciences, a pioneer in single-cell sequencing technology, today announced a new collaboration with Basepair to provide point and click bioinformatic analysis of single-cell data produced with its patented and disruptive combinatorial indexing technology.
These include reports to help researchers assess their data quality and produce a cell-gene matrix compatible with open-source standard single-cell analysis workflows like Seurat and Scanpy.
“Challenges related to analysis and interpretation of sequencing data are still one of the most common bottlenecks that researchers face when adopting new next-generation sequencing applications, especially those that create large amounts of data,” said Giovanna Prout, CEO of Scale Biosciences.
“With our groundbreaking federated approach to analysis, we look forward to helping Scale Biosciences’ customers better understand their data and accelerate their research without it ever needing to leave their direct control.”

Arima Genomics Announces New Partnership with Basepair to Accelerate Bioinformatics Analysis of 3D Genomics Data

Retrieved on:

Donnerstag, November 3, 2022

Arima Genomics, Inc., the leader in 3D genomics, today announced a new partnership with Basepair to empower scientists with new options for bioinformatic analysis of 3D genomic data.

Key Points:

Arima Genomics, Inc., the leader in 3D genomics, today announced a new partnership with Basepair to empower scientists with new options for bioinformatic analysis of 3D genomic data.
"This partnership brings our customers more bioinformatics options and enables those without bioinformatics support to understand their data with an easy-to-use analysis tool," said Anthony Schmitt, PhD, SVP of Science at Arima Genomics.
"Basepair offers a range of automated pipelines for next-generation sequencing analysis and looks forward to enabling Arima's customers with faster and easier analysis of 3D genomics data," said Amit Sinha, PhD, Founder of Basepair.
"We are confident that Arima Genomics' customers will find great value in our platform's ability to reduce compute time and generate meaningful insights from Arima data."

Base Pair Biotechnologies Announces Fast Track SBIR Grant Award from National Institutes of Health

Retrieved on:

Donnerstag, Februar 21, 2019

Branches of biology, Nucleic acids, Organic compounds, Morphine, Psychoactive drugs, Aptamer, Biotechnology, Peptides, Neonatology, Neonatal withdrawal, Opioid, Base pair

Aptamer-Based Point-Of-Care Tests for Opioids, to Rapidly Diagnose Neonatal Abstinence Syndrome

Key Points:

Aptamer-Based Point-Of-Care Tests for Opioids, to Rapidly Diagnose Neonatal Abstinence Syndrome
PEARLAND, Texas, Feb. 21, 2019 /PRNewswire/ --Base Pair Biotechnologies, Inc., the Aptamer Discovery Company, announced today the receipt of a Fast Track Small Business Innovation Research grant from the National Institute on Drug Abuse of the National Institutes of Health.
The grant will be used to develop a new platform to detect opioids and their primary metabolites in newborns.
Base Pair is an angel-backed aptamer discovery company located near Houston, close to major medical centers.
Base Pair utilizes a highly consultative service model, leveraging a breadth of technical capability and commercial experience to meet its customers' needs.